SNHG7 contributes to the development of prostate cancer by promoting glycolysis via the SRSF1/c-Myc axis in two prostate cancer cell lines, PC-3 and DU-145 (Liu et al., 2022b). Here, SRSF1 is linked to prostate carcinoma.